|
MechanismGLUT1 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Circle33 LLC
0 Patents (Medical) associated with Circle33 LLC
100 Deals associated with Circle33 LLC
100 Translational Medicine associated with Circle33 LLC